台股 » 個股 » 逸達 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

逸達

(6576)
  • 股價
    79.1
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    32
  • 產業
    上櫃 生技醫療類股
  • 118人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
逸達 (6576)籌碼相關-富邦-台南 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/2004/0104/037577.58082.58587.5May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

富邦-台南 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/0100.00178.2079.10-1205-0.49%
2025/03/31178.7000.0078.3012060.48%
2025/03/28181.9000.0081.6012030.49%
2025/03/2700.00082.1783.0002030.00%
2025/03/26083.9000.0083.4002030.00%
2025/03/25084.1000.0083.4002030.00%
2025/03/24083.9000.0083.5002070.00%
2025/03/20082.9000.0083.0001990.00%
2025/03/17084.6000.0084.2001970.00%
2025/03/14083.7000.0083.5002020.00%
2025/03/12084.9000.0084.5002010.00%
2025/03/050.585.2000.0084.900.52050.24%
2025/02/21086.3000.0086.0002360.00%
2025/02/191086.33186.0086.0092323.88%
2025/02/17186.50186.4086.3002260.00%
2025/02/1300.00184.6083.90-1219-0.45%
2025/02/12283.4500.0083.5022170.92%
2025/02/11182.4000.0084.2012160.46%
2025/02/1000.00181.0080.80-1209-0.48%
2025/02/07280.2000.0080.0022050.97%
2025/02/0600.00179.6079.50-1202-0.49%
2025/02/04176.9000.0077.3011990.50%
2025/01/20176.3000.0076.3011950.51%
2025/01/14076.50476.2576.30-4194-2.06%
2025/01/1300.00375.6076.10-3194-1.54%
2024/12/30077.3000.0077.7001860.00%
2024/12/2700.00277.7077.70-2185-1.08%
2024/12/2600.00377.2777.80-3183-1.64%
2024/12/1700.00473.4573.80-4166-2.40%
2024/12/1600.00572.6072.90-5164-3.03%
2024/12/10174.2100.0073.4011560.65%
2024/12/09075.8000.0075.4001490.01%
2024/12/05178.4000.0078.0011400.71%
2024/11/2600.00179.1079.40-1132-0.75%
2024/11/2500.00179.7080.30-1128-0.78%
2024/11/21178.30278.3079.40-1108-0.92%
2024/11/1900.00076.1076.800102-0.01%
2024/11/14377.2300.0075.8031042.86%
2024/11/08279.30179.4079.3011070.94%
2024/11/04177.0000.0076.6011100.91%
2024/10/2900.00178.0077.80-1123-0.81%
2024/10/24279.5000.0078.8021351.48%
2024/10/22076.8000.0076.8001370.01%
2024/10/170.378.100.578.0078.70-0.2144-0.15%
2024/10/04182.4000.0082.4011680.59%
2024/09/26182.3000.0081.9011870.53%
2024/09/2500.00182.5082.30-1192-0.52%
2024/08/20180.0000.0080.0012930.34%
2024/08/09177.500.277.7477.500.82990.26%
2024/08/08175.4000.0076.4013000.33%
2024/08/0700.00174.8076.60-1302-0.33%
2024/08/06170.6000.0072.0013010.33%
2024/08/051.574.3300.0072.501.52990.50%
2024/08/01180.0000.0080.4012900.34%
2024/07/29180.9000.0079.5012890.35%
2024/07/260.281.3000.0081.300.22860.07%
2024/07/1500.00183.0083.40-1284-0.35%
2024/07/11184.0000.0083.4012800.36%
2024/07/02284.1000.0084.3022740.73%
2024/07/0100.00083.4084.5002720.00%
2024/06/283.183.60483.6883.50-0.9270-0.35%
2024/06/2600.00184.0084.30-1266-0.38%
2024/06/25282.10181.5083.5012600.38%
2024/06/24288.8000.0089.2022380.84%
2024/06/2100.00197.8097.40-1224-0.44%
2024/06/2000.00698.7798.40-6223-2.68%
2024/06/1800.00299.0598.50-2221-0.90%
2024/06/12697.2700.0097.5062232.69%
2024/06/111.197.6500.0097.401.12230.50%
2024/06/07398.90199.1099.6022200.91%
2024/06/060.496.1200.0095.800.42070.19%
2024/05/30194.3000.0094.9012310.43%
2024/05/2800.00196.0095.90-1239-0.42%
2024/05/27194.2000.0094.3012410.41%
2024/05/21294.3000.0094.6022620.76%
2024/05/20694.6800.0094.7062702.21%
2024/05/17294.6000.0095.0022860.70%
2024/05/1600.00294.2094.00-2317-0.63%
2024/05/13193.9000.0094.1013240.31%
2024/05/07194.1000.0094.4013190.31%
2024/05/06195.3000.0094.6013180.31%
2024/04/30196.1000.0095.9013190.31%
2024/04/2600.00094.7595.0003180.00%
2024/04/2500.00095.0095.1003190.00%
2024/04/24094.0000.0095.1003210.00%
2024/04/22194.0000.0094.0013310.30%
2024/04/191.494.9800.0093.601.43390.40%
2024/04/160.295.90296.2096.80-1.8334-0.53%
2024/04/15798.8600.0098.3073312.11%
2024/04/12499.0000.0099.4043311.21%
2024/04/1000.002100.5099.40-2330-0.60%
2024/04/09298.602100.0099.1003320.00%
2024/04/0800.005.299.8799.60-5.2329-1.56%
逸達兒童中樞性早熟三期臨床 三度獲DSMB正面回饋持續進行Anue鉅亨-2025/02/17
逸達受美國經銷商指示不定期出貨 1月營收年減逾6成Anue鉅亨-2025/02/08
逸達前列腺癌新劑型新藥 確立美國藥證審查完成目標日Anue鉅亨-2025/01/14
逸達 相關文章
逸達 相關影音
 
 
321小時34